January 17, 2017

For the fourth consecutive year, NCPA asked its members to rank legislative priorities. For the 115th Congress, the top three concerns are DIR fees, generic pricing transparency and any willing provider provision.

January 17, 2017

The publication of the draft guidance means that stakeholders can now comment for 60 days after Jan. 18 in order for comments to be considered before the final version of the guidance is written

January 17, 2017
According to QuintilesIMS data, brand and generic sales for 100-mg strength amiodarone tablets were $23 million for the 12 months ended November 2016. 
 
January 12, 2017

Two-pack of generic carries a $109.99 price tag.

January 11, 2017

The drug is indicated to treat certain types of seizures in patients older than 13 years of age. 

January 10, 2017

The Philadelphia Inquirer is reporting that Heritage Pharmaceuticals’s former CEO and chairman, Jeffrey Glazer, and former SVP commercial operations, Jason Malek, admitted in federal court that between April 2013 and December 2015, they worked together to manipulate prices of  Heritage’s generics of doxycycline hyclate and glyburide. The two face up to 10 years in prison each. After the two were indicted 20 states filed suit against six generics companies, including Heritage. (Philadelphia Inquirer)

January 10, 2017
The transaction is part of the European Commission’s antitrust divestiture requirements surrounding Teva’s acquisition of Allergan’s generics business. 
 
January 10, 2017

The drug is indicated to treat and prevent influenza A and as a treatment for parkinsonism and drug-induced extrapyramidal reactions. 

January 6, 2017
The drug is indicated to treat or prevent bronchospasm in adults, adolescents and children 6 years of age and older with reversible obstructive airway disease. 
January 4, 2017

Sandoz‘s generic will be available in 40-, 80- and 125-mg dosage strengths.

January 3, 2017

The Food and Drug Administration approved three generics from New Jersey-based specialty generics company Teligent on the last day of 2016, the company announced Tuesday.

January 3, 2017

Lupin in the last week of 2016 received tentative approval for its generics of Benicar tablets, Giazo tablets and Livalo tablets. 

January 3, 2017

The company on Thursday announced the launch of its generics of Concerta extended-release tablets, Zovia tablets and Cerebyx injection. 

December 21, 2016

Walgreens has expanded the availability of prescription-free naloxone to 33 states and the District of Columbia.

December 16, 2016

Carrying a wholesale acquisition cost of $300 per injection, it will reach pharmacies in a week.

December 15, 2016

The drug’s availability comes a year after the Food and Drug Administration approved it as a follow-on biologic to Lantus, another U-100 long-acting insulin. It has an amino acid sequence identical to that of Lantus. 

December 12, 2016

Alvogen and Natco Pharma on Monday announced the launch of their generic of Tamiflu (oseltamivir phosphate) capsules, the first generic of the flu treatment to hit the U.S. market. The generic was approved by the Food and Drug Administration in August.

December 12, 2016
Par’s generic is entitled to market exclusivity based on the first-to-file status of the application filed by its licensing partners, Glenmark Pharmaceuticals USA. 
December 7, 2016

President Obama said in his Dec. 3 weekly address that he would sign the legislation into law "as soon as it reaches my desk."

December 7, 2016

In an interview with Time published Tuesday morning to accompany his being chosen as the magazine’s “Person of the Year,” President-elect Donald Trump told the magazine that one of his goals as president is lowering the cost of prescription drugs.  

December 7, 2016

The drug had U.S. sales of about $75 million for the 12-month period ended October 2016. 

December 6, 2016

Aurobindo’s generic will be available in 20- and 40-mg dosage strengths. 

December 6, 2016

The drug had about $42 million in U.S. sales for the 12 months ended Oct. 31, 2016, according to QuintilesIMS data. 

December 6, 2016
The drug had U.S. sales of $14.4 million for the 12 months ended September 2016.